Insufficient scRNA-seq data for expression of BMP10 at single-cell level.
Insufficient scRNA-seq data for expression of BMP10 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| liver | 99% | 73.38 | 224 / 226 | 5% | 0.14 | 19 / 406 |
| heart | 71% | 12008.59 | 609 / 861 | 0% | 0 | 0 / 0 |
| stomach | 53% | 5.97 | 190 / 359 | 1% | 0.01 | 2 / 286 |
| lung | 52% | 22.62 | 299 / 578 | 0% | 0 | 0 / 1155 |
| skin | 50% | 3.77 | 913 / 1809 | 0% | 0 | 0 / 472 |
| muscle | 46% | 2.47 | 370 / 803 | 0% | 0 | 0 / 0 |
| adipose | 43% | 3.17 | 518 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 43% | 5.11 | 571 / 1335 | 0% | 0 | 0 / 0 |
| peripheral blood | 42% | 2.53 | 389 / 929 | 0% | 0 | 0 / 0 |
| breast | 41% | 15.53 | 187 / 459 | 0% | 0.01 | 2 / 1118 |
| bladder | 38% | 0.95 | 8 / 21 | 0% | 0 | 0 / 504 |
| intestine | 37% | 2.33 | 361 / 966 | 0% | 0.00 | 1 / 527 |
| esophagus | 37% | 1.84 | 528 / 1445 | 0% | 0 | 0 / 183 |
| ovary | 36% | 2.51 | 65 / 180 | 0% | 0 | 0 / 430 |
| thymus | 36% | 6.32 | 232 / 653 | 0% | 0 | 0 / 605 |
| uterus | 35% | 1.46 | 60 / 170 | 0% | 0 | 0 / 459 |
| adrenal gland | 34% | 1.37 | 87 / 258 | 0% | 0 | 0 / 230 |
| spleen | 34% | 1.42 | 81 / 241 | 0% | 0 | 0 / 0 |
| brain | 33% | 2.33 | 861 / 2642 | 0% | 0 | 0 / 705 |
| prostate | 32% | 1.62 | 79 / 245 | 0% | 0 | 0 / 502 |
| kidney | 30% | 1.25 | 27 / 89 | 0% | 0 | 0 / 901 |
| pancreas | 29% | 1.21 | 95 / 328 | 0% | 0 | 0 / 178 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0055015 | Biological process | ventricular cardiac muscle cell development |
| GO_0032924 | Biological process | activin receptor signaling pathway |
| GO_0060298 | Biological process | positive regulation of sarcomere organization |
| GO_0055009 | Biological process | atrial cardiac muscle tissue morphogenesis |
| GO_0060045 | Biological process | positive regulation of cardiac muscle cell proliferation |
| GO_0010613 | Biological process | positive regulation of cardiac muscle hypertrophy |
| GO_0060347 | Biological process | heart trabecula formation |
| GO_0010628 | Biological process | positive regulation of gene expression |
| GO_1903242 | Biological process | regulation of cardiac muscle hypertrophy in response to stress |
| GO_0001822 | Biological process | kidney development |
| GO_0060391 | Biological process | positive regulation of SMAD protein signal transduction |
| GO_0007155 | Biological process | cell adhesion |
| GO_0010614 | Biological process | negative regulation of cardiac muscle hypertrophy |
| GO_0055010 | Biological process | ventricular cardiac muscle tissue morphogenesis |
| GO_0030509 | Biological process | BMP signaling pathway |
| GO_0060038 | Biological process | cardiac muscle cell proliferation |
| GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
| GO_0007512 | Biological process | adult heart development |
| GO_2000138 | Biological process | positive regulation of cell proliferation involved in heart morphogenesis |
| GO_0030336 | Biological process | negative regulation of cell migration |
| GO_0045214 | Biological process | sarcomere organization |
| GO_0010596 | Biological process | negative regulation of endothelial cell migration |
| GO_0055117 | Biological process | regulation of cardiac muscle contraction |
| GO_0061036 | Biological process | positive regulation of cartilage development |
| GO_0030308 | Biological process | negative regulation of cell growth |
| GO_0005615 | Cellular component | extracellular space |
| GO_0005576 | Cellular component | extracellular region |
| GO_0030018 | Cellular component | Z disc |
| GO_0009986 | Cellular component | cell surface |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0005179 | Molecular function | hormone activity |
| GO_0008083 | Molecular function | growth factor activity |
| GO_0031433 | Molecular function | telethonin binding |
| GO_0033612 | Molecular function | receptor serine/threonine kinase binding |
| GO_0005515 | Molecular function | protein binding |
| GO_0005125 | Molecular function | cytokine activity |
| Gene name | BMP10 |
| Protein name | Bone morphogenetic protein 10 (BMP-10) |
| Synonyms | |
| Description | FUNCTION: Required for maintaining the proliferative activity of embryonic cardiomyocytes by preventing premature activation of the negative cell cycle regulator CDKN1C/p57KIP and maintaining the required expression levels of cardiogenic factors such as MEF2C and NKX2-5. Acts as a ligand for ACVRL1/ALK1, BMPR1A/ALK3 and BMPR1B/ALK6, leading to activation of SMAD1, SMAD5 and SMAD8 transcription factors. Inhibits endothelial cell migration and growth. May reduce cell migration and cell matrix adhesion in breast cancer cell lines. . |
| Accessions | ENST00000295379.2 O95393 |